Search results
Results from the WOW.Com Content Network
Pages in category "Drugs developed by AbbVie" The following 128 pages are in this category, out of 128 total. This list may not reflect recent changes. A. ABT-436;
Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name
For premium support please call: 800-290-4726 more ways to reach us
Sales for Amgen's top drug, Neulasta/Neupogen, made up 33% of total sales for the first nine months of 2012. Enbrel, the company's next highest-selling product, accounted for 25%. The AbbVie to be
You are likely aware that AbbVie has generated an enormous chuck of its revenue in recent years from just one drug. Immunology megablockbuster Humira brought in $9.3 billion in sales in 2012 - or ...
Drugs developed by AbbVie (128 P) Pages in category "AbbVie" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes. ...
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.